Silence Therapeutics Plc (SLNCF)
1.06
0.00 (0.00%)
USD |
OTCM |
Jun 09, 16:00
Silence Therapeutics EPS Diluted (Quarterly) : -0.1055 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| NuCana Plc | -1.28 |
| Mereo BioPharma Group Plc | -0.0418 |
| Compass Pathways Plc | -0.3044 |
| Immunocore Holdings Plc | 0.2446 |
| Genflow Biosciences Plc | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -14.96M |
| Revenue (Quarterly) | 0.422M |
| Total Expenses (Quarterly) | 15.38M |
| Enterprise Value | 80.26M |
| Gross Profit Margin (Quarterly) | 72.27% |
| Profit Margin (Quarterly) | -3.54K% |
| Earnings Yield | -49.95% |
| Normalized Earnings Yield | -49.34 |